TCAP: Platelet Inhibitor Treated Patients With Head Injury Trauma Meeting NICE Criteria : is the CT-scan Mandatory ?

Sponsor
Rennes University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT03687528
Collaborator
(none)
3,200
12
53.6
266.7
5

Study Details

Study Description

Brief Summary

At the emergencies rooms, patients with head trauma meeting one of the NICE criteria, which include antiplatelet inhibitors treatment, are considered as patients with a risk of cerebral haemorrage and are taken systematically for a CT-scanner.

However, there are more and more antiplatelet inhibitor's patient with minor head injury traumas seen at the emergencies room and the efficiency of this NICE criteria is controversial on litterature.

This study aims to determine that the absence of no other NICE criteria than antiplatelet inhibitors is a sufficient condition to eliminate a cerebral haemorrhage for patients with head injury traumas, and conversely, that antiplatelet inhibitors treatment would not be by itself an indication for a CT-scanner.

Condition or Disease Intervention/Treatment Phase
  • Radiation: CT-scanner

Detailed Description

Head injuries are a frequent reason for emergency services, and according to studies, they represent between 5% and 10% of patients treated in emergencies. Among them, 90% are minor head injury traumas. NICE criteria has been defined to establish patients who need a CT-scanner because of a risk of cerebral haemorrhage.

NICE criteria include several conditions including taking antiplatelet inhibitors. However, the real risk of cerebral haemorrhage for theses cases is controversial in litterature. In parallel, more and more patients undergoing antiplatelet inhibitor's treatment are seen in emergencies after a head injury trauma.

In routine protocol at the emergency rooms, these patients are seen for a clinical exam and next submitted to a CT-scanner. If the clinician can't detect a cerebral haemorrage, the patient will return at home.

This study aims to determine that the absence of no other NICE criteria than antiplatelet inhibitors treatment is a sufficient condition to eliminate a cerebral haemorrhage for patients with head injury traumas, and conversely, that antiplatelet inhibitors treatment would not be by itself an indication for a CT-scanner.

This is a diagnostic, case-only, prospective, multicenter study with a blinded primary outcome measure assessment.

As described in routine protocol, in this study antiplatelet inhibitor's patients with head injury trauma will be seen for a clinical exam and next submitted to a CT-scanner. After a month, patient will be called by the clinical center to ask about morbidity and mortality. Especially, clinicans will report on the emergence of a cerebral haemorrhage during this month.

Study Design

Study Type:
Observational
Anticipated Enrollment :
3200 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Platelet Inhibitor Treated Patients With Head Injury Trauma Without Any Clinical Symptoms of Cerebral Haemorrhage (NICE Criteria) : is the CT-scan Mandatory ?
Actual Study Start Date :
Jun 15, 2020
Anticipated Primary Completion Date :
Dec 1, 2024
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Patient with minor head injury trauma

The emergency protocol for antiplatelet inhibitors treated patient with head injury trauma and meeting others NICE criteria involves a clinical exam followed by a CT-scanner.

Radiation: CT-scanner
After a clinical exam, patient have a CT-scanner to check any cerebral haemorrhage.

Outcome Measures

Primary Outcome Measures

  1. Existence of a cerebral haemorrhage at the CT-scanner. [1 day]

    Cerebral haemorrhage seen at the CT-scanner.

Secondary Outcome Measures

  1. Neurosurgeries' rate after one month [1 month]

    Neurosurgeries' rate after one month

  2. Existence of a cerebral haemorrhage associated to death [1 month]

    Existence of a cerebral haemorrhage associated to death

  3. Existence of a cerebral haemorrhage associated to neurosurgery [1 month]

    Existence of a cerebral haemorrhage associated to neurosurgery

  4. Existence of a cerebral haemorrhage associated to hospitalization with more than 24h of intubation [1 month]

    Existence of a cerebral haemorrhage associated to hospitalization with more than 24h of intubation

  5. Existence of a cerebral haemorrhage associated to more than 2 nights at hospital [1 month]

    Existence of a cerebral haemorrhage associated to more than 2 nights at hospital

  6. Death rate after one month [1 month]

    Death rate after one month

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • At least 18 years old

  • Patient with a head injury trauma, described by the patient or seen at the clinical exam

  • Glasgow score between 13 and 15 at the clinical exam

  • Current treatment with antiplatelet inhibitors

  • Informed non opposition form signed

Exclusion Criteria :
  • Absence of CT-scanner

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU d'Angers Angers France
2 CHU Brest Brest France
3 CH Chartres Chartres France
4 CH Le Mans Le Mans France
5 CH Bretagne Sud, Lorient Lorient France
6 CHU de Nantes Nantes France
7 CHU de Poitiers Poitiers France
8 CH Bretagne Sud - Quimperlé Quimperlé France
9 CHU de Rennes Rennes France 35033
10 CH de Saint Brieuc Saint-Brieuc France
11 CH de Saint Malo Saint-Malo France
12 CH Bretagne Atlantique Vannes France

Sponsors and Collaborators

  • Rennes University Hospital

Investigators

  • Principal Investigator: Jérémie BONENFANT, Md, Rennes University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rennes University Hospital
ClinicalTrials.gov Identifier:
NCT03687528
Other Study ID Numbers:
  • 35RC17_8839_T.CAP
First Posted:
Sep 27, 2018
Last Update Posted:
Jan 5, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Rennes University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 5, 2022